1
0
0
News
9th GPCRs in Medicinal ChemistryRSC BMCS
www.rscbmcs.org
Daniel Meibom Bayer AG, Germany BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α2B Antagonist. Noureldin Saleh Schrodinger, USA Accurate ... Daniel Meibom Bayer AG, Germany BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α2B Antagonist. Noureldin Saleh Schrodinger, USA Accurate ...
So schön ist es, Weihnachtslieder zu singen | Helmstedt | Salzgitter ...
www.salzgitter-zeitung.de
Für St. Stephani-Pfarrer Daniel Meibom-Glebe war es der Augenblick, als die Orgel bei „O du Fröhliche“ die fünfte Strophe ausließ und die Menschen ohne ... › article › So...
BAY-6096: A Potent, Selective, and Highly Water-Soluble ...x-mol.com
newsletter.x-mol.com
— Daniel Meibom 1 , Jutta Meyer 1 , Clemens-Jeremias von Buehler 1 , Karl D Collins 1 , Stefanie Maassen 1 , Kersten Matthias Gericke
Rund 100 neue Ganztagsplätze entstehen - Stadt Helmstedt
www.stadt-helmstedt.de
— „Die Nachfragen nach Plätzen sind oft an uns herangetragen worden“, macht Pfarrer Daniel Meibom-Glebe deutlich. „Jetzt können wir für Eltern ... › rathaus › presse › artikel
Netzwerk-Profile
LinkedIn: Daniel Meibom - Laborleiter - Bayer | LinkedIn
Sehen Sie sich das Profil von Daniel Meibom auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 1 Job ist im Profil von Daniel Meibom aufgelistet.
Business-Profile
Daniel MEIBOM | Senior Scientist | Medicinal Chemist, PhDResearchGate
www.researchgate.net
Daniel Meibom. Bayer Pharma Research Center, Wuppertal, Germany · Medicinal Chemistry. Medicinal Chemist, PhD. Daniel Meibom. Bayer Pharma Research Center, Wuppertal, Germany · Medicinal Chemistry. Medicinal Chemist, PhD.
patentbuddy: Daniel Meibom
BAYER PHARMA AKTIENGESELLSCHAFT, Leverkusen, DE
Pistoia Alliance: Employee DirectoryZoomInfo
www.zoominfo.com
Results of 42 — Contact Name profile photo for Daniel Meibom Daniel Meibom · Contact Info Email Direct · Job Title · Location. United States, Massachusetts, ...
Bücher
Daniel Meibom | Bayer Corporation | 52 PublicationsAI Chat for scientific PDFs | SciSpace
typeset.io
Daniel Meibom is an academic researcher from Bayer Corporation. The author has contributed to research in topics: Medicine & Sulfanyl. Daniel Meibom is an academic researcher from Bayer Corporation. The author has contributed to research in topics: Medicine & Sulfanyl.
Daniel Meibom | Bayer | 19 Publications | 266 CitationsAI Chat for scientific PDFs | SciSpace
typeset.io
Daniel Meibom is an academic researcher from Bayer. The author has contributed to research in topics: Prodrug & Receptor. The author has an hindex of 8, ... Daniel Meibom is an academic researcher from Bayer. The author has contributed to research in topics: Prodrug & Receptor. The author has an hindex of 8, ...
Hamm, Hermann DanielGermanistik im Netz
www.germanistik-im-netz.de
MDCCXVII. Autor*in: Göbel, Johann Wilhelm von ; Hamm, Hermann Daniel ; Meibom, Brandan. Erschienen: [1717]. Verlag: Typis Hermanni ... MDCCXVII. Autor*in: Göbel, Johann Wilhelm von ; Hamm, Hermann Daniel ; Meibom, Brandan. Erschienen: [1717]. Verlag: Typis Hermanni ...
Sulfated Copper Oxide Catalyzed One-Pot Synthesis of N ...
www.tandfonline.com
von S Jayashree · — Franz von Nussbaum, Volkhart M. Li, Daniel Meibom, Sonja Anlauf, Martin Bechem, Martina Delbeck,. Michael Gerisch, Axel Harrenga, ... › doi › pdf
Dokumente zum Namen
Predictive Modeling of PROTAC Cell Permeability with ...DiVA portal
www.diva-portal.org
von V Poongavanam · · Zitiert von: 9 — Daniel Meibom, and Jan Kihlberg*. Cite This: ACS Omega 2023, 8, Daniel Meibom − Drug Discovery Sciences, Bayer AG, Wuppertal ... von V Poongavanam · · Zitiert von: 9 — Daniel Meibom, and Jan Kihlberg*. Cite This: ACS Omega 2023, 8, Daniel Meibom − Drug Discovery Sciences, Bayer AG, Wuppertal ...
GPCRs in Medicinal Chemistryeventsforce.net
cdn.eventsforce.net
Daniel Meibom Bayer AG, Germany. Structural Characterization of an Orphan GPCR. Reveals a Novel Mechanism of Inverse Agonism. Seungil Han Pfizer, USA. The ... Daniel Meibom Bayer AG, Germany. Structural Characterization of an Orphan GPCR. Reveals a Novel Mechanism of Inverse Agonism. Seungil Han Pfizer, USA. The ...
Solution Conformations Shed Light on PROTAC Cell ...DiVA portal
www.diva-portal.org
von Y Atilaw · · Zitiert von: 109 — Daniel Meibom − Drug Discovery Sciences, Bayer AG, Wuppertal, Germany. Mate Erdelyi − Department of Chemistry - BMC, Uppsala. von Y Atilaw · · Zitiert von: 109 — Daniel Meibom − Drug Discovery Sciences, Bayer AG, Wuppertal, Germany. Mate Erdelyi − Department of Chemistry - BMC, Uppsala.
BAY-7081: A Potent, Selective, and Orally ACS Publications
pubs.acs.org
von D Meibom — BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Daniel Meibom*. vor 6 Tagen — Daniel Meibom. d. and Jan Kihlberg. a. ,. *. a. Department of Chemistry. -. BMC, Box 576, Uppsala University, SE Uppsala, Sweden. › doi › abs
Wissenschaftliche Veröffentlichungen
Novel non-xanthine antagonist of the A2B adenosine ...ScienceDirect.com
www.sciencedirect.com
von M Härter · · Zitiert von: 16 — , Simone Schulz c , Raimund Kast b , Daniel Meibom a , Niels Lindner a. Show more. Add to Mendeley. Share. Cite. https://doi.org j. von M Härter · · Zitiert von: 16 — , Simone Schulz c , Raimund Kast b , Daniel Meibom a , Niels Lindner a. Show more. Add to Mendeley. Share. Cite. https://doi.org j.
Roles of eicosanoids in pulmonary fibrosisJ-Stage
www.jstage.jst.go.jp
Hartmut Beck, Tobias Thaler, Daniel Meibom, et al. Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of ... Hartmut Beck, Tobias Thaler, Daniel Meibom, et al. Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of ...
Veröffentlichungen allgemein
Diversity-Oriented Synthesis of Substituted Pyrazolo[4,3-d] ...ResearchGate
www.researchgate.net
Daniel Meibom at Bayer Pharma Research Center, Wuppertal, Germany. Daniel Meibom ... Daniel Meibom · Marcus Bauser · Heinrich Meier · Dieter Häbich. ChemInform is ... Daniel Meibom at Bayer Pharma Research Center, Wuppertal, Germany. Daniel Meibom ... Daniel Meibom · Marcus Bauser · Heinrich Meier · Dieter Häbich. ChemInform is ...
G-6 -l - Digitale Bibliothek BraunschweigYumpu
www.yumpu.com
— der tote Daniel Meibom aber, sein Opfer, wegen angenommener Mitschuld daneben. an den Füßen aufgeknüpft worden.
Linker-Dependent Folding Rationalizes PROTAC MediFind
www.medifind.com
— Authors. Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel, Anja Giese, Lutz Lehmann, Daniel Meibom, Mate Erdelyi, Jan Kihlberg. › articles
Artikel & Meinungen
Twitter-Nachrichten: Ingo HartungTwitter
today by Daniel Meibom. @BayerPharma . Prodrug strategies add another level of complexity (to usually already complex discovery challenges).
Sonstiges
HK A1 - 取代的氧代吡啶衍生物Google Patents
patents.google.com
Daniel Meibom: Dieter Lang. Worldwide applications JO. Application number: JOP A. Filing date: Legal status: CU. Application number ... Daniel Meibom: Dieter Lang. Worldwide applications JO. Application number: JOP A. Filing date: Legal status: CU. Application number ...
US B2 - Substituted arylimidazolone and triazolone as ...Google
www.google.com
Daniel Meibom: Dirk Schneider: Verena Voehringer: Chantal Fürstner: Jörg Keldenich: Dieter Lang: Elisabeth Pook: Carsten Schmeck; Current Assignee (The listed ... Daniel Meibom: Dirk Schneider: Verena Voehringer: Chantal Fürstner: Jörg Keldenich: Dieter Lang: Elisabeth Pook: Carsten Schmeck; Current Assignee (The listed ...
Daniel Meibom ProfileIDiyas
idiyas.com
Daniel Meibom profile page. Bio and statistics: company filing history, issued patents, published patent applications. Daniel Meibom profile page. Bio and statistics: company filing history, issued patents, published patent applications.
ADAMTS12 - Drugs, Indications, PatentsPatSnap Synapse
synapse.patsnap.com
Daniel Meibom ; Pierre Wasnaire ; Kristin Beyer ; Andreas Broehl ; Yolanda Cancho-Grande ; Nadine Elowe ; Kerstin Henninger ; Sarah Johannes ; Natalia ... Daniel Meibom ; Pierre Wasnaire ; Kristin Beyer ; Andreas Broehl ; Yolanda Cancho-Grande ; Nadine Elowe ; Kerstin Henninger ; Sarah Johannes ; Natalia ...
Abstract : Endothelial Dysfunction in a Large Animal ...AHA Journals
www.ahajournals.org
von M Wu · — Claudia Grah; ,; Sven Moosmang; ,; Daniel Meibom; and; Stefan Janssens ... Daniel Meibom. Daniel Meibom. Search for more papers by this author. von M Wu · — Claudia Grah; ,; Sven Moosmang; ,; Daniel Meibom; and; Stefan Janssens ... Daniel Meibom. Daniel Meibom. Search for more papers by this author.
BAY-7081: A Potent, Selective, and Orally Bioavailable ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von D Meibom · · Zitiert von: 3 — Daniel Meibom , Sina Micus , Anna Lena Andreevski , Sonja Anlauf , Pamela Bogner , Clemens-Jeremias von Buehler , André P ... von D Meibom · · Zitiert von: 3 — Daniel Meibom , Sina Micus , Anna Lena Andreevski , Sonja Anlauf , Pamela Bogner , Clemens-Jeremias von Buehler , André P ...
Chiral discrimination in cycloaddition experimentsRSC Publishing
pubs.rsc.org
von C Borm · · Zitiert von: 6 — Claudia Borm, Daniel Meibom and Ekkehard Winterfeldt. Abstract. Various applications of a chiral cyclopentadiene in chiral recognition experiments are ... von C Borm · · Zitiert von: 6 — Claudia Borm, Daniel Meibom and Ekkehard Winterfeldt. Abstract. Various applications of a chiral cyclopentadiene in chiral recognition experiments are ...
Commemorative Issue in Honor of Prof. Binne Zwanenburg ...Arkivoc
www.arkat-usa.org
von RM Kellogg — Daniel Meibom, Hilmar Weinmann and Ekkehard Winterfeldt. Full Text: PDF (224K) pp received Aug ; accepted Oct ; published Oct ; von RM Kellogg — Daniel Meibom, Hilmar Weinmann and Ekkehard Winterfeldt. Full Text: PDF (224K) pp received Aug ; accepted Oct ; published Oct ;
Discovery of the First Orally Bioavailable ADAMTS7 InhibitorNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von D Meibom — Daniel Meibom , Pierre Wasnaire , Kristin Beyer , Andreas Broehl , Yolanda Cancho-Grande , Nadine Elowe , Kerstin Henninger ... von D Meibom — Daniel Meibom , Pierre Wasnaire , Kristin Beyer , Andreas Broehl , Yolanda Cancho-Grande , Nadine Elowe , Kerstin Henninger ...
Dr alexandros vakalopoulosPatentsPatent Guru
www.patentguru.com
... Daniel Meibom Dr., Hans-georg Lerchen Frank, Submeier Dr., Barbara Albrecht-kupper Dr., Katja Zimmermann, Assignee: BAYER INTELLECTUAL PROPERTY GMBH, IPC Daniel Meibom Dr., Hans-georg Lerchen Frank, Submeier Dr., Barbara Albrecht-kupper Dr., Katja Zimmermann, Assignee: BAYER INTELLECTUAL PROPERTY GMBH, IPC ...
EFMC-ISMC Confirmed SpeakersEFMC-ISMC 2024
www.efmc-ismc.org
BAYER PHARMA Read more. Dr Daniel MEIBOM. ×. Dr Daniel MEIBOM. BAYER PHARMA Wuppertal, Germany. Daniel Meibom received his PhD degree in Organic Chemistry under ... BAYER PHARMA Read more. Dr Daniel MEIBOM. ×. Dr Daniel MEIBOM. BAYER PHARMA Wuppertal, Germany. Daniel Meibom received his PhD degree in Organic Chemistry under ...
EFMC-ISMC CommitteesLD Organisation
www.ldorganisation.com
Dr Daniel MEIBOM (Bayer Pharma, Wuppertal, Germany). Eric NICOLAI. Dr Laiyin NIE ( WuXi AppTec, Germany). Prof. Katarina NIKOLIC (University of Belgrade ... Dr Daniel MEIBOM (Bayer Pharma, Wuppertal, Germany). Eric NICOLAI. Dr Laiyin NIE ( WuXi AppTec, Germany). Prof. Katarina NIKOLIC (University of Belgrade ...
KJIM :: Korean Journal of Internal MedicineThe Korean Journal of Internal Medicine
www.kjim.org
Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen, Lisa Dietz, Carsten Terjung, Michaela Bairlein, Clemens-Jeremias von Bühler ... Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen, Lisa Dietz, Carsten Terjung, Michaela Bairlein, Clemens-Jeremias von Bühler ...
Linker-dependent folding rationalizes PROTAC cell ...ChemRxiv
chemrxiv.org
von V Poongavanam · · Zitiert von: 45 — Daniel Meibom ,; Mate Erdelyi ,; Jan Kihlberg. Show author details. This content is a preprint and has not undergone peer review at the time of ... von V Poongavanam · · Zitiert von: 45 — Daniel Meibom ,; Mate Erdelyi ,; Jan Kihlberg. Show author details. This content is a preprint and has not undergone peer review at the time of ...
Orateurs confirmLD Organisation
www.ldorganisation.com
Dr Daniel MEIBOM. (BAYER PHARMA, Wuppertal, Allemagne). Dr Christel MENET. (GALAPAGOS, Brussels, Belgique). Dr Sylviane MULLER. (IBMC-CNRS, Strasbourg, France). Dr Daniel MEIBOM. (BAYER PHARMA, Wuppertal, Allemagne). Dr Christel MENET. (GALAPAGOS, Brussels, Belgique). Dr Sylviane MULLER. (IBMC-CNRS, Strasbourg, France).
Patents Related To "Loss of Akt1 Leads to Severe ...expertkg.com
www.expertkg.com
DANIEL MEIBOM et. al. BAYER et. al. BAYER AKTIENGESELLSCHAFT et al , Cardiovascular imaging and functional analysis system · Citation: 56 Related ... DANIEL MEIBOM et. al. BAYER et. al. BAYER AKTIENGESELLSCHAFT et al , Cardiovascular imaging and functional analysis system · Citation: 56 Related ...
Potent and Selective Human Neutrophil Elastase Inhibitors ...Sigma-Aldrich
www.sigmaaldrich.com
Franz von Nussbaum, Volkhart M Li, Daniel Meibom, Sonja Anlauf, Martin Bechem, Martina Delbeck, Michael Gerisch, Axel Harrenga, Dagmar Karthaus, Dieter Lang ... Franz von Nussbaum, Volkhart M Li, Daniel Meibom, Sonja Anlauf, Martin Bechem, Martina Delbeck, Michael Gerisch, Axel Harrenga, Dagmar Karthaus, Dieter Lang ...
Predictive Modeling of PROTAC Cell Permeability with ...ChemRxiv
chemrxiv.org
von V Poongavanam · · Zitiert von: 9 — Daniel Meibom ,; Jan Kihlberg. Show author details. This content is a preprint and has not undergone peer review at the time of posting ... von V Poongavanam · · Zitiert von: 9 — Daniel Meibom ,; Jan Kihlberg. Show author details. This content is a preprint and has not undergone peer review at the time of posting ...
Previous Issuearkat usa
www.arkat-usa.org
High pressure chiral recognition experiments – a route to homochiral 4-fluorocyclohexenones (BZ-860EP) Daniel Meibom, Hilmar Weinmann and Ekkehard Winterfeldt High pressure chiral recognition experiments – a route to homochiral 4-fluorocyclohexenones (BZ-860EP) Daniel Meibom, Hilmar Weinmann and Ekkehard Winterfeldt
RICT Drug Discovery and SelectionBOSS XVIII Symposium
www.boss-symposium.org
Dr Daniel MEIBOM. (BAYER PHARMA, Wuppertal, Germany). Session Session 10: Structure Based Approaches. Sponsored by 'Fondation de la Maison de la Chimie ... Dr Daniel MEIBOM. (BAYER PHARMA, Wuppertal, Germany). Session Session 10: Structure Based Approaches. Sponsored by 'Fondation de la Maison de la Chimie ...
sortiert nach Relevanz / Datum